Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

136.94 +1.30 (+0.96%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 637,786
Open 136.02
Bid (Size) 136.36 (1)
Ask (Size) 137.56 (1)
Prev. Close 135.64
Today's Range 135.35 - 137.16
52wk Range 119.59 - 145.58
Shares Outstanding 122,180,759
Dividend Yield 2.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-2.76%
-2.76%
1 Month
+5.31%
+5.31%
3 Month
+10.63%
+10.63%
6 Month
+2.28%
+2.28%
1 Year
+1.64%
+1.64%

More News

Read More
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Peering Into Quest Diagnostics's Recent Short Interest
Via Benzinga
The Analyst Landscape: 5 Takes On Quest Diagnostics
Via Benzinga
Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic
Via Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:DGX.
Via Chartmill
Key Takeaways From Quest Diagnostics Analyst Ratings
Via Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
Via Chartmill
DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'
Via Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
Via MarketBeat
(DGX) - Analyzing Quest Diagnostics's Short Interest
Via Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
Via Chartmill
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For April 23, 2024
Via Benzinga
Is NYSE:DGX suited for dividend investing?
Via Chartmill
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
Via Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Via Benzinga
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
Via Benzinga
Topics Bonds
Exposures Debt Markets
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Earnings Outlook For Quest Diagnostics
Via Benzinga
Earnings Scheduled For February 1, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.